{"database": "openregs", "table": "federal_register", "rows": [["2011-18562", "Medicare Program; Meeting of the Medicare Evidence Development and Coverage Advisory Committee-September 21, 2011", "Notice", "This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) (\"Committee\") will be held on Wednesday, September 21, 2011. The Committee generally provides advice and recommendations concerning the adequacy of scientific evidence needed to determine whether certain medical items and services can be covered under the Medicare statute. This meeting will focus on the currently available evidence regarding antivascular endothelial growth factor (anti-VEGF) treatment of diabetic macular edema (DME). This meeting is open to the public in accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)).", "2011-07-22", 2011, 7, "https://www.federalregister.gov/documents/2011/07/22/2011-18562/medicare-program-meeting-of-the-medicare-evidence-development-and-coverage-advisory", "https://www.govinfo.gov/content/pkg/FR-2011-07-22/pdf/2011-18562.pdf", "Health and Human Services Department; Centers for Medicare & Medicaid Services", "221,45", "This notice announces that a public meeting of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) (\"Committee\") will be held on Wednesday, September 21, 2011. The Committee generally provides advice and recommendations concerning...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2011-18562"], "units": {}, "query_ms": 0.3335120854899287, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}